PSI Journal Club: Limitations and Challenges with Mixed Model Repeated Measures (MMRM) Analysis
Moses Mwangi and Florian Lasch present their recent work on MMRM, with discussion lead by Geert Molenberghs.
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides
Joint PSI Pharmaceutical Statistics & Royal Statistical Society (RSS)
Audio Recordings
Webcast
CHAIR: James Carpenter, LSHTM
Royal Statistical Society (RSS)
Speaker: Abdus S. Wahed, University of Pittsburgh
Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia
Co-author: Peter F. Thall;
Journal of the Royal Statistical Society: Series C (Applied Statistics), Volume 62, Issue 1, Pages 67–83, January 2013
Abstract | Paper+ | Slides
Statisticians in the Pharmaceutical Industry (PSI)
Speaker: Nicola Schmitt, AstraZeneca
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Co-authors: S. Hong, A. Stone, J. Denne
Pharmaceutical Statistics, Volume 11, Issue 5, pages 394-402, September/October 2012
Abstract | Paper+ | Slides